Department of Neurology

Leon Cai explains his poster to Sharon Kam (center) and Katherine Lee at the 2022 Alzheimer’s Disease Research Day.
April 7, 2022

Event highlights research on Alzheimer’s disease

The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

Vanderbilt Center for Tourette Syndrome and Other Tic Disorders team members include, from left, Angela White, RN, Mariana Ciobanu, MD, KellyAnn Primm, OTR/L, David Isaacs, MD, MPH, Heather Riordan, MD, Michelle Eckland, Jessica Stroh, RN, and Kayla Johnson, PharmD.
February 23, 2022

VUMC designated a Tourette syndrome center of excellence

The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence.

Research by Dane Chetkovich, MD, PhD, right, Ye Han, PhD, and colleagues on how antidepressants work points to possible new targets for drug development.
December 1, 2021

Study provides new insight into how antidepressant drugs work

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.

October 21, 2021

Doctors seeing increase in young females with tics, verbal outbursts similar to Tourette syndrome

An international phenomenon of involuntary movements and vocalizations in adolescent girls is now believed to be a functional movement disorder, and while the causes are unclear, TikTok and other social medial platforms may be important contributors.

October 20, 2021

New Clinician Spotlight: Ryan Merrell

Neuro-oncologist Ryan Merrell, MD, has joined Vanderbilt University Medical Center as chief of the Division of Neuro-Oncology in the Department of Neurology.

October 18, 2021

Mental health screening in epilepsy

Sending survey tools to epilepsy patients before their clinic appointment doubled the numbers of patients who were diagnosed and treated for depression and anxiety disorders, Vanderbilt neurologists found.